Skip to main content
logo
Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
17.28
-1.07 (-5.83%)
At close: Nov 2, 2026, 4:00 PM EST
17.30
+0.02 (0.12%)
After-hours: Nov 2, 2026, 7:30 PM EST

Relay Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
3,7871,4666901,3571,8063,318
Market Cap Growth
200.46%112.63%-49.19%-24.86%-45.56%-11.11%
Enterprise Value
2,906903-1006018132,725
Last Close Price
17.288.464.1211.0114.9430.71

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
365.8795.4968.9153.131307.871095.42
PB Ratio
4.242.590.891.811.903.70
P/TBV Ratio
4.252.590.891.811.913.71

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
280.8258.82-23.53588.46899.58

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.030.060.060.070.060.03
Net Debt / Equity Ratio
-0.99-0.92-0.94-0.93-0.99-1.04
Net Debt / EBITDA Ratio
2.861.761.931.863.074.21
Net Debt / FCF Ratio
4.152.212.922.293.9512.01
Asset Turnover
0.010.020.010.030.000.00
Quick Ratio
17.9321.6815.4024.7815.7639.60
Current Ratio
18.2722.6115.9525.4416.0040.14
Return on Equity (ROE)
-36.77%-41.12%-44.15%-40.18%-31.44%-43.81%
Return on Assets (ROA)
-22.88%-25.16%-28.11%-24.40%-18.44%-15.63%
Return on Capital Employed (ROCE)
-33.90%-50.40%-47.00%-46.60%-30.00%-23.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-9.09%-18.86%-48.97%-25.20%-16.08%-10.97%
FCF Yield
-5.60%-16.09%-36.41%-22.43%-13.21%-2.35%
Buyback Yield / Dilution
-12.39%-20.10%-16.55%-9.21%-17.97%-123.22%
SEC Filings: 10-K · 10-Q